Keyword Connections

•  David Haas

Resources

• No matching connections

Communities

• No matching connections

Publications

• Transmission of Mycobacterium tuberculosis from health care workers.
  Sterling TR, Haas DW
  (2006) N Engl J Med 355: 118-21
• Three months of rifapentine and isoniazid for latent tuberculosis infection.
  Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, TB Trials Consortium PREVENT TB Study Team
  (2011) N Engl J Med 365: 2155-66
• A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
  Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH
  (1989) N Engl J Med 320: 545-50
• The case against anergy testing as a routine adjunct to tuberculin skin testing.
  Slovis BS, Plitman JD, Haas DW
  (2000) JAMA 283: 2003-7
• Effect of treating co-infections on HIV-1 viral load: a systematic review.
  Modjarrad K, Vermund SH
  (2010) Lancet Infect Dis 10: 455-63
• Treatment of Mycobacterium tuberculosis infection: time to get a move on?
  Menzies D, Sterling TR
  (2014) Ann Intern Med 161: 449-50
• Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence.
  Fatima S, Kamble SS, Dwivedi VP, Bhattacharya D, Kumar S, Ranganathan A, Van Kaer L, Mohanty S, Das G
  (2020) J Clin Invest 130: 655-661
• Where next for gene expression profiling? So much promise.
  Noth I, Gibson KF, Drake WP
  (2011) Am J Respir Crit Care Med 184: 1102-3
• Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.
  Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD
  (2001) Proc Natl Acad Sci U S A 98: 7958-63
• Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
  Podust LM, Poulos TL, Waterman MR
  (2001) Proc Natl Acad Sci U S A 98: 3068-73
• Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.
  Sousa AO, Mazzaccaro RJ, Russell RG, Lee FK, Turner OC, Hong S, Van Kaer L, Bloom BR
  (2000) Proc Natl Acad Sci U S A 97: 4204-8
• Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis.
  Bellamine A, Mangla AT, Nes WD, Waterman MR
  (1999) Proc Natl Acad Sci U S A 96: 8937-42
• Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells.
  Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G
  (2010) Proc Natl Acad Sci U S A 107: 21653-8
• Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.
  Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW, Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams
  (2015) Clin Infect Dis 60: 1860-3
• Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.
  Sterling TR, Moro RN, Borisov AS, Phillips E, Shepherd G, Adkinson NF, Weis S, Ho C, Villarino ME, Tuberculosis Trials Consortium
  (2015) Clin Infect Dis 61: 527-35
• Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.
  Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL
  (2017) Clin Infect Dis 64: 111-115
• The Relationship Between Latent Tuberculosis Infection and Acute Myocardial Infarction.
  Huaman MA, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Rondan PL, Henson D, Ticona C, Sterling TR, Fichtenbaum CJ, Garvy BA
  (2018) Clin Infect Dis 66: 886-892
• Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis.
  Algood HM, Lin PL, Flynn JL
  (2005) Clin Infect Dis 41 Suppl 3: S189-93
• RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.
  Hamilton CD, Swaminathan S, Christopher DJ, Ellner J, Gupta A, Sterling TR, Rolla V, Srinivasan S, Karyana M, Siddiqui S, Stoszek SK, Kim P
  (2015) Clin Infect Dis 61Suppl 3: S155-9
• Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.
  Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL
  (2017) Clin Infect Dis 64: e1-e33
• Chemokines and tuberculosis.
  Algood HM, Chan J, Flynn JL
  (2003) Cytokine Growth Factor Rev 14: 467-77
• Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.
  Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BE, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR
  (2013) AIDS 27: 1321-9
• Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype.
  McIlleron HM, Schomaker M, Ren Y, Sinxadi P, Nuttall JJ, Gous H, Moultrie H, Eley B, Merry C, Smith P, Haas DW, Maartens G
  (2013) AIDS 27: 1933-40
• Multidrug-resistant tuberculosis at an HIV testing center in Haiti.
  Joseph P, Severe P, Ferdinand S, Goh KS, Sola C, Haas DW, Johnson WD, Rastogi N, Pape JW, Fitzgerald DW
  (2006) AIDS 20: 415-8
• Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
  Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M
  (2015) Eur Respir J 46: 1563-76
• Molecular analysis of sarcoidosis tissues for mycobacterium species DNA.
  Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ
  (2002) Emerg Infect Dis 8: 1334-41
• Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
  Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
  (2011) J Infect Dis 204: 893-901
• An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice.
  Kaul V, Bhattacharya D, Singh Y, Van Kaer L, Peters-Golden M, Bishai WR, Das G
  (2012) J Infect Dis 206: 1816-25